We are thrilled to announce that Converge Bio has been selected for the highly competitive AWS GenAI Accelerator program in partnership with NVIDIA, Meta, 𝗮𝗻𝗱 Mistral AI. Out of 4,500 global applicants from 129 countries, we were handpicked to receive up to $1 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗰𝗹𝗼𝘂𝗱 𝗰𝗿𝗲𝗱𝗶𝘁𝘀 to promote our GenAI solutions for advanced AI in biology. This strategic collaboration brings us one step closer to realizing our mission of harnessing Generative AI trained directly on biological data to help bring better treatments to patients.

A huge thank you to AWS Startups for this incredible opportunity. Being part of the AWS GenAI Accelerator is a major milestone for us, and we are eager to leverage the support and resources provided by AWS to push the boundaries of AI innovation.

Check out The Washington Post article listing Converge Bio and the rest of the Startups shaping the future of generative AI.